Literature DB >> 32716032

ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.

Daniel Strayve1, Mustafa S Makia1, Mashal Kakakhel1, Haarthi Sakthivel1, Shannon M Conley2,3, Muayyad R Al-Ubaidi1,4,5, Muna I Naash1,4,5.   

Abstract

Peripherin 2 (PRPH2) is a retina-specific tetraspanin protein essential for the formation of rod and cone photoreceptor outer segments (OS). Patients with mutations in PRPH2 exhibit severe retinal degeneration characterized by vast inter- and intra-familial phenotypic heterogeneity. To help understand contributors to this within-mutation disease variability, we asked whether the PRPH2 binding partner rod OS membrane protein 1 (ROM1) could serve as a phenotypic modifier. We utilized knockin and transgenic mouse models to evaluate the structural, functional and biochemical effects of eliminating one allele of Rom1 (Rom1+/-) in three different Prph2 models which mimic human disease: C213Y Prph2 (Prph2C/+), K153Del Prph2 (Prph2K/+) and R172W (Prph2R172W). Reducing Rom1 in the absence of Prph2 mutations (Rom1+/-) had no effect on retinal structure or function. However, the effects of reducing Rom1 in the presence of Prph2 mutations were highly variable. Prph2K/+/Rom1+/- mice had improved rod and cone function compared with Prph2K/+ as well as amelioration of K153Del-associated defects in PRPH2/ROM1 oligomerization. In contrast, Prph2R172W/Rom1+/- animals had worsened rod and cone function and exacerbated retinal degeneration compared with Prph2R172W animals. Removing one allele of Rom1 had no effect in Prph2C/+. Combined, our findings support a role for non-pathogenic ROM1 null variants in contributing to phenotypic variability in mutant PRPH2-associated retinal degeneration. Since the effects of Rom1 reduction are variable, our data suggest that this contribution is specific to the type of Prph2 mutation.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32716032      PMCID: PMC7530533          DOI: 10.1093/hmg/ddaa160

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

1.  Overexpression of ROM-1 in the cone-dominant retina.

Authors:  Dibyendu Chakraborty; Shannon M Conley; Zack Nash; Xi-Qin Ding; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa.

Authors:  May Nour; Steven J Fliesler; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

3.  Intrafamilial clinical heterogeneity associated with a novel mutation of the retinal degeneration slow/peripherin gene.

Authors:  Francesca Simonelli; Francesco Testa; Valeria Marini; Emanuela Interlandi; Settimio Rossi; Derri Roman Pognuz; Gianni Virgili; Cecilia Garrè; Francesco Bandello
Journal:  Ophthalmic Res       Date:  2007-09-12       Impact factor: 2.892

4.  Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa.

Authors:  T P Dryja; L B Hahn; K Kajiwara; E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-09       Impact factor: 4.799

5.  Suppression of rds expression by siRNA and gene replacement strategies for gene therapy using rAAV vector.

Authors:  Hilda Petrs-Silva; Douglas Yasumura; Michael T Matthes; Matthew M LaVail; Alfred S Lewin; William W Hauswirth
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Expanding the Clinical and Molecular Heterogeneity of Nonsyndromic Inherited Retinal Dystrophies.

Authors:  Ana Rodríguez-Muñoz; Elena Aller; Teresa Jaijo; Emilio González-García; Ana Cabrera-Peset; Roberto Gallego-Pinazo; Patricia Udaondo; David Salom; Gema García-García; José M Millán
Journal:  J Mol Diagn       Date:  2020-02-07       Impact factor: 5.568

7.  ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype.

Authors:  Charlotte M Poloschek; Michael Bach; Wolf A Lagrèze; Esther Glaus; Johannes R Lemke; Wolfgang Berger; John Neidhardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

8.  Prph2 initiates outer segment morphogenesis but maturation requires Prph2/Rom1 oligomerization.

Authors:  Shannon M Conley; Michael W Stuck; Jamie N Watson; Rahel Zulliger; Justin L Burnett; Muna I Naash
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

9.  A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles.

Authors:  Xue Cai; Zack Nash; Shannon M Conley; Steven J Fliesler; Mark J Cooper; Muna I Naash
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

10.  Initiation of rod outer segment disc formation requires RDS.

Authors:  Dibyendu Chakraborty; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more
  2 in total

Review 1.  Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.

Authors:  Wanqin Liu; Shanshan Liu; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

2.  Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease.

Authors:  Jana Zernant; Winston Lee; Jun Wang; Kerry Goetz; Ehsan Ullah; Takayuki Nagasaki; Pei-Yin Su; Gerald A Fishman; Stephen H Tsang; Santa J Tumminia; Brian P Brooks; Robert B Hufnagel; Rui Chen; Rando Allikmets
Journal:  PLoS Genet       Date:  2022-03-30       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.